GlassScriptPhysician profile
Joseph M Curry
NPI 1043427172
$19,855.54
in general payments reported to CMS, 2019-2025
13 companies · $2,118 in 2025
The $2,118 reported for 2025 was more than what 90% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2021: $3,549 · 2022: $268 · 2023: $84.80 · 2024: $381 · 2025: $2,118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,358 · Food and Beverage: $1,225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,358.33 |
| Food and Beverage | $1,225.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $12,559.26 | 2019 | |
| Intuitive Surgical, INC. | $3,525.15 | 2021 | |
| Medical Device Business Services, INC. | $1,578.70 | 2025 | Matrixcombo |
| Astrazeneca Pharmaceuticals LP | $858.85 | 2019 | |
| Baxter Healthcare | $686.88 | 2022-2025 | |
| Medtronic, INC. | $175.00 | 2025 | Propel |
| Stryker Corporation | $169.93 | 2025 | Na, Vsp System, Vsp Cranial |
| Depuy Synthes Sales INC. | $125.83 | 2019-2024 | Trumatch |
| Atos Medical INC | $84.80 | 2023 | Provox Life Home Hme |
| Glaxosmithkline, LLC. | $71.85 | 2021-2025 | Nucala |
| Karl Storz Endoscopy-America | $19.29 | 2024 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Curry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.